TheEdgeResearch
Home / Stocks / SEPSF

Asep Medical Holdings Inc (SEPSF)

OTC Healthcare Biotechnology
$0.01 ▲ +0.00%
Market Cap
$118,414
Sector
Healthcare
Industry
Biotechnology
Beta
-1.84
52-Wk Range
0.0109-0.387
CEO
Richard Heinzl
Country
CA
Currency
USD

Asep Medical Holdings Inc operates in the Biotechnology industry of the Healthcare sector, headquartered in Victoria, BC, CA. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $118,414. On trailing twelve-month figures it carries a trailing P/E of -0.42, a net margin of -1223.0%. Its beta of -1.84 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.42
Price / Sales
4.84
Price / Book
0.72
EV / EBITDA
-1.02
Gross margin
-70.9%
Operating margin
-676.2%
Net margin
-1223.0%
Return on equity
—
Debt / equity
0.06
Current ratio
0.12
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
6
IPO date
2022-02-01
Headquarters
Victoria, BC, CA
About Asep Medical Holdings Inc

Asep Medical Holdings Inc., operating primarily through its subsidiary ASEP Medical Inc., is dedicated to advancing both a rapid diagnostic system for Sepsis and a range of peptide-based therapeutic treatments applicable across various medical conditions. The company, initially incorporated in 2020 under the name Trenchant Life Sciences Investment Corp., later rebranded to its present title, Asep Medical Holdings Inc. Its corporate base of operations is located in Vancouver, Canada.

Comparable companies

Asep Medical Holdings Inc is most often compared with the following Healthcare names:

ALSECNBIELVAYHCYTDMSITFPCNTRADCQSBUDFSLGWFSPLIF
More research on SEPSF
SEPSF technical analysis SEPSF TheEdge Score Compare against peers
Open full interactive analysis & DCF →